We previously reported that NEP stabilizes PKCδ protein expression in prostate cancer cells by inhibiting neuropeptide-induced Src signaling, which in the absence of NEP results in PKCδ protein degradation (34). This evidence concerns the gene MME and prostate carcinoma.